Higashida R T, Halbach V V, Barnwell S L, Dowd C, Dormandy B, Bell J, Hieshima G B
Department of Radiology, Interventional Neuroradiology Section, San Francisco, CA 94143-0628.
AJNR Am J Neuroradiol. 1990 Jul-Aug;11(4):633-40.
Treatment of intracranial arterial aneurysms by interventional neurovascular techniques is now being performed in selected cases. From a transfemoral approach, under local anesthesia, a detachable silicone microballoon can be guided through the intracranial circulation, directed into the aneurysm, inflated with a polymerizing agent for solidification, and detached. The goal is to exclude the aneurysm from the circulation and preserve flow through the parent artery. Since 1984, 84 patients have been treated by this technique. The patients ranged in age from 15 to 83 years (mean age, 48) and included 63 females and 21 males. The distribution of aneurysms included 59 in the anterior circulation and 25 in the posterior circulation. The presenting symptom or cause was mass effect in 45 patients (53.6%), subarachnoid hemorrhage in 31 patients (36.9%), carotid-cavernous sinus fistula resulting from rupture of an intracavernous aneurysm in six cases (7.1%), trauma in one case, and transient cerebral ischemia due to emboli in one case. Permanent complications directly related to therapy included 15 deaths and nine cases of stroke. Clinical and radiologic follow-ups were performed 1, 3, and 12 months after treatment; duration of follow-up ranged from 3 to 68 months (mean, 35.5 months). In 65 cases (77.4%) there was evidence of complete aneurysmal occlusion, and in 19 cases 922.6%) there was subtotal occlusion greater than 85%. Interventional techniques for treatment of intracranial aneurysms may be useful as a therapeutic alternative in those patients not amenable to standard surgical therapy.
目前,在特定病例中正在采用介入性神经血管技术治疗颅内动脉瘤。通过经股动脉途径,在局部麻醉下,可将可脱性硅胶微球囊经颅内循环引导至动脉瘤内,注入聚合剂使其膨胀固化,然后使其脱离。目的是将动脉瘤从循环中排除,并保持通过载瘤动脉的血流。自1984年以来,已有84例患者接受了该技术治疗。患者年龄范围为15至83岁(平均年龄48岁),其中女性63例,男性21例。动脉瘤分布包括前循环59例,后循环25例。出现的症状或病因包括45例(53.6%)有占位效应,31例(36.9%)蛛网膜下腔出血,6例(7.1%)海绵窦内动脉瘤破裂导致的颈内动脉海绵窦瘘,1例创伤,1例因栓子导致的短暂性脑缺血。与治疗直接相关的永久性并发症包括15例死亡和9例中风。治疗后1个月、3个月和12个月进行临床和影像学随访;随访时间为3至68个月(平均35.5个月)。65例(77.4%)有动脉瘤完全闭塞的证据,19例(22.6%)有大于85%的次全闭塞。对于那些不适合标准手术治疗的患者,介入技术治疗颅内动脉瘤可能是一种有用的治疗选择。